Hepatoblastoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Podcasts
• Clinical Trials

A Compassionate Use Program to Provide Access to Sodium Thiosulfate
Condition:   Cisplatin-Induced Hearing Loss in Children Who Had Standard-risk Hepatoblastoma Intervention:   Drug: Sodium Thiosulfate (STS) Sponsors:   TRPHARM;   Fennec Pharma;   Klinar CRO Available (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 21, 2019 Category: Research Source Type: clinical trials